🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some experts stated the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has removed problematic content and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.

Within minutes of joining one group, a vendor posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts show black plastic parcels with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to potentially significant medical dangers”.